Medical Association – Civilav Med http://civilavmed.com/ Fri, 24 Sep 2021 09:41:25 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://civilavmed.com/wp-content/uploads/2021/04/default-150x150.png Medical Association – Civilav Med http://civilavmed.com/ 32 32 As COVID-19 deaths in Texas rise, more people under 60 die https://civilavmed.com/as-covid-19-deaths-in-texas-rise-more-people-under-60-die/ https://civilavmed.com/as-covid-19-deaths-in-texas-rise-more-people-under-60-die/#respond Fri, 24 Sep 2021 09:00:00 +0000 https://civilavmed.com/as-covid-19-deaths-in-texas-rise-more-people-under-60-die/

Delta brings age change in deaths

“Angry and frustrated” by the new wave of COVID-19


Source link

]]>
https://civilavmed.com/as-covid-19-deaths-in-texas-rise-more-people-under-60-die/feed/ 0
SPHPMA Achieves National Recognition For Efforts To Reduce The Number Of Patients With Uncontrolled Blood Pressure https://civilavmed.com/sphpma-achieves-national-recognition-for-efforts-to-reduce-the-number-of-patients-with-uncontrolled-blood-pressure/ https://civilavmed.com/sphpma-achieves-national-recognition-for-efforts-to-reduce-the-number-of-patients-with-uncontrolled-blood-pressure/#respond Thu, 23 Sep 2021 18:55:27 +0000 https://civilavmed.com/sphpma-achieves-national-recognition-for-efforts-to-reduce-the-number-of-patients-with-uncontrolled-blood-pressure/

St. Peter’s Health Partners Medical Associates (SPHPMA) has been recognized by the American Heart Association (AHA) and the American Medical Association (AMA) for our commitment to helping improve blood pressure (BP) control rates among the patient populations we serve, earning Gold + level recognition under the 2021 Goal: BP ™ Recognition Program.

The Gold + award recognizes practices that have demonstrated a commitment to measurement accuracy and in which 70 percent or more of their adult patient population have controlled high blood pressure. Hypertension (high BP) is a major risk factor in the United States for heart attacks and strokes that can often be prevented or managed if diagnosed and treated correctly. Managing blood pressure is essential for better cardiovascular health.

Target: BP is a national collaboration between the AHA and AMA to reduce the number of Americans who suffer from heart attacks and strokes each year by urging physicians, health systems and patients to donate priority to BP control. The initiative aims to help healthcare organizations improve blood pressure control rates through the use of AMA MAP BP ™ evidence-based protocols and recognizes SPHPMA’s commitment to improving blood pressure control. blood pressure.

Congratulations to all!


Source link

]]>
https://civilavmed.com/sphpma-achieves-national-recognition-for-efforts-to-reduce-the-number-of-patients-with-uncontrolled-blood-pressure/feed/ 0
California bride sues for ivermectin for COVID patient https://civilavmed.com/california-bride-sues-for-ivermectin-for-covid-patient/ https://civilavmed.com/california-bride-sues-for-ivermectin-for-covid-patient/#respond Thu, 23 Sep 2021 00:04:53 +0000 https://civilavmed.com/california-bride-sues-for-ivermectin-for-covid-patient/

A California woman has become the latest person to ask a judge to order the use of ivermectin for COVID-19 treatment.

The Bakersfield woman filed a lawsuit in Kern County Superior Court on Friday asking that the San Joaquin Community Hospital be forced to administer the pest control drug to her 66-year-old husband, who is in the ward. intensive care since August 23. He tested positive for COVID-19 on August 20.

The “declaratory medical emergency complaint” says a doctor prescribed ivermectin for the man but the prescriptions were not filled and the chief medical officer at Bakersfield Hospital said the drug was not part of the protocol.

The complaint says the hospital has exhausted its treatment options and the patient is “literally on the verge of death.”

The controversial drug has been promoted for the treatment of COVID by Republican lawmakers, conservative talk show hosts and some doctors. So far, there has been a randomized, placebo-controlled trial, preliminary results of which indicate that there is no benefit as a COVID treatment.

Ivermectin has been approved for the treatment of parasitic worms and head lice, but its use to treat COVID-19 has resulted in overdoses and hospitalizations. Ivermectin toxicity can cause nausea, vomiting, diarrhea, low blood pressure, confusion, seizures and death.

This month, the American Medical Association and two groups of pharmacists called for an “immediate end” to the drug’s use outside of research. The Food and Drug Administration issued a warning titled “Why You Shouldn’t Use Ivermectin to Treat or Prevent COVID-19.”

The Bakersfield case is one of a series of cases filed in recent weeks by patients and their families. Among them:

• A woman from Ohio on August 20 requested that her 51-year-old husband receive treatment. A judge approved the emergency order three days later, but a higher court revoked it on September 6. The doctor who prescribed the drug said he was unsure whether it benefited the patient. The wife said she and her husband had not been vaccinated because they did not trust the “experimental” vaccine.

• An Illinois woman on August 30 lost her attempt to force a Springfield hospital to give the drug to her 61-year-old husband. The man, who was not vaccinated, contracted COVID-19 in July and ended up on a ventilator and dialysis. His wife told the State Journal-Register that the couple knew about the drug because they had given it to their German Shepherds against parasites.

• A Kentucky RN sued Sept. 9, asking that a Louisville hospital be ordered to give her 58-year-old husband ivermectin as well as intravenous vitamin C. On September 15, a judge denied his request for an emergency order.

• A complaint filed on September 17 seeks to force a Delaware hospital to use the treatment on a 54-year-old man who has been hospitalized since September 7.

• A Chicago suburban hospital in Libertyville fought back in court on September 21 after being ordered to let a COVID-19 patient receive the drug. He said the 68-year-old’s heart rate plunged to 28 beats per minute after receiving a “mega dose” of the drug, the Chicago Tribune reported.